VeriMompalmitamine은 임신 중 안전한가요?
Palmitamine (1-hexadecylamine / hexadecan-1-amine, CAS 143-27-1) is not listed with a harmonised reproductive classification on ECHA and there are no SCCS or CIR safety assessments or peer-reviewed reproductive studies indicating teratogenicity or reproductive hazard; regulatory and database sources instead list acute skin/eye corrosivity concerns. Therefore default hazard/mechanism scores are 0 and exposure is set to low (1) for topical cosmetic use because the compound is lipophilic and used in formulations where some dermal exposure is plausible. ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.005.088?utm_source=openai))
Related ingredients
Frequently asked questions
- palmitamine은 임신 중 안전한가요?
- Palmitamine (1-hexadecylamine / hexadecan-1-amine, CAS 143-27-1) is not listed with a harmonised reproductive classification on ECHA and there are no SCCS or CIR safety assessments or peer-reviewed reproductive studies indicating teratogenicity or reproductive hazard; regulatory and database sources instead list acute skin/eye corrosivity concerns. Therefore default hazard/mechanism scores are 0 and exposure is set to low (1) for topical cosmetic use because the compound is lipophilic and used in formulations where some dermal exposure is plausible. ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.005.088?utm_source=openai))
- palmitamine은 모유 수유 중 안전한가요?
- No data were found showing reproductive or lactation toxicity or transfer into milk; no harmonised classification for reproductive effects exists. Topical exposure could lead to low but measurable systemic exposure, so exposure is scored as low (1) in absence of milk-transfer data. ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.005.088?utm_source=openai))
- palmitamine은 아기 피부에 안전한가요?
- There are no infant-specific reproductive or developmental hazard data. Applying the scoring rules, exposure for 0–3 yr skin is increased by +1 because hexadecylamine is a dermally-active, lipophilic primary amine with documented skin‑corrosive/irritant properties in SDSs and therefore measurable dermal uptake is plausible in infants (immature barrier, higher SA:BW). Hazard and mechanism remain 0 absent evidence of reproductive or endocrine effects. ([merckmillipore.com](https://www.merckmillipore.com/Web-INTL-Site/en_US/-/USD/ShowDocument-File?Country=SG&Display=inline&DocumentId=822203_SDS_SG_EN.PDF&DocumentType=MSD&DocumentUID=351857216&Language=EN&Origin=null&ProductSKU=MDA_CHEM-822203&utm_source=openai))
- VeriMom은 palmitamine을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 palmitamine을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 palmitamine 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.